| #137 |
Jacob RIFFEY |
Dsm Ip Assets B.V. |
3 |
| #137 |
Chad Sugiyama |
Dsm Ip Assets B.V. |
3 |
| #137 |
Kirt C. Weidner |
Omega Design |
3 |
| #137 |
Geoffrey Richard Koontz |
Puricore |
3 |
| #137 |
Vineeth Voruganti |
— |
3 |
| #137 |
Steve Forbes |
— |
3 |
| #137 |
Allan B. Owen |
Vickers |
3 |
| #137 |
Norman Bennett |
Schramm |
3 |
| #137 |
Sylvie Laguerre |
Microdose Therapeutx |
3 |
| #137 |
Eddie Kebin Geng |
Shpp Global Technologies B.V. |
3 |
| #137 |
Qingtong Ge |
Federal-Mogul Powertrain |
3 |
| #137 |
Donald D. Joye |
US Air Force |
3 |
| #137 |
Dmitry Avdeev |
Aps Technology |
3 |
| #137 |
Benjamin Biber |
Totalenergies Onetech |
3 |
| #137 |
Leonard A. Dube |
— |
3 |
| #137 |
Barry M. Gross |
Moore Push-Pin |
3 |
| #137 |
Howard M. Swope, III |
Navteq B.V. |
3 |
| #137 |
Chadwick E. Dean |
The Antioch Company |
3 |
| #137 |
Gerald Thomas Lien |
Federal-Mogul Worldwide |
3 |
| #137 |
William Garzon-Rodriguez |
Prometic Biotherapeutics |
3 |
| #137 |
Kasumo Morris |
Allscripts Software |
3 |
| #137 |
Jin Duck Park |
Samsung |
3 |
| #173 |
Thomas C. Mullin |
Arco Chemical Technology |
2 |
| #173 |
Alexander R. Ochman |
Melior Pharmaceuticals I |
2 |
| #173 |
Ramanujam Raman |
Bentley Systems, Incorporated |
2 |
| #173 |
Satish Raj Katakam |
JPMorgan Chase |
2 |
| #173 |
Kenan Aksu |
— |
2 |
| #173 |
Paul Keeler |
Unknown |
2 |
| #173 |
Venkataraman Pranatharthiharan |
The Neat Company |
2 |
| #173 |
Zeena Kottukapally CHERIAN |
Hercules |
2 |
| #173 |
Cullen L. MYERS |
Venatorx Pharmaceuticals |
2 |
| #173 |
Raul Perales |
— |
2 |
| #173 |
Melissa Schroder Viscomi |
Wells Fargo Bank, N.A. |
2 |
| #173 |
Anthony Conley |
Merck |
2 |
| #173 |
Stephen M. LoCastro |
Smithkline Beecham Limited |
2 |
| #173 |
Joseph F. Moran |
— |
2 |
| #173 |
Stephen F. Harned |
Bentley Systems, Incorporated |
2 |
| #173 |
Scott Donnelly |
Idemia France |
2 |
| #173 |
Wenzi Pan |
3-Dimensional Pharmaceuticals |
2 |
| #173 |
Frank Fatato |
Fenner U.S. |
2 |
| #173 |
Richard S. Hujsak |
Analytical Graphics |
2 |
| #173 |
Andrew Allen |
Smithkline Beecham Limited |
2 |
| #173 |
Aideen C. O'Brien |
— |
2 |
| #173 |
Juan José Marugán Sánchez |
3-Dimensional Pharmaceuticals |
2 |
| #173 |
Raymond B. Wolfgang |
Purdue Research Foundation |
2 |
| #173 |
Linda Barone |
Johnson & Johnson |
2 |
| #173 |
Zhengdong Wu |
3-Dimensional Pharmaceuticals |
2 |
| #173 |
Nagi Maley |
Bp Corporation North America |
2 |
| #173 |
Linden Wei |
Elan Pharma International |
2 |
| #173 |
Peter G. Schirk |
— |
2 |